Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase IIb study of cabazitaxel in metastatic colorectal cancer resistant to standard treatment
2011-001218-32Phase 2Terminated
- Sponsor
- Nasasbiotech
- Start
- Apr 2012
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cabazitaxel in colorectal cancer (CRC) (2 arms), sponsored by Nasasbiotech. Started Apr 2012; status: terminated.
02
Drugs
cabazitaxel
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2011-001218-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001218-32.